India's Cipla global CEO Umang Vohra to step down
Oct 30 (Reuters) - Indian drugmaker Cipla CIPL.NS said on Thursday its global chief executive and managing director, Umang Vohra, will step down, effective March 2026. Achin Gupta, Cipla's global chief operating officer, will take over the top role from Vohra, with effect from April 1, 2026. (Reporting by Kashish Tandon in Bengaluru; Editing by Rashmi Aich) ((Kashish.Tandon@thomsonreuters.com; 8800437922;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate